drugset / Trial / NCT01497002

Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a

NCT01497002 ↗

Phase 3 Completed 1222 enrolled University of Leipzig
RandomizedParallel-groupOpen-labelTreatment

Summary

Improvement of the treatment-results in elderly patients with acute myeloid leukemia through intensification of consolidation chemotherapy and/or allografting as consolidative immunotherapy

Timeline

Start
2005-04
Primary completion
2018-07-18
Completion
2018-07-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule 100 mg/m2 Intravenous
Subject Cytarabine Small molecule 1 g Intravenous
Subject Human Stem Cells Cell therapy — —